undefined
EUTM file information

018191309

INOVO


February 2, 2020

Trademark Summary

The trademark INOVO was filed by Werner Trenker, a national of the Republic of Austria (the "Applicant"). The application was published for oppositions on February 18, 2020, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on May 17, 2020 by Unilab LP on Likelihood of confusion. the opponent was represented by KONDRAT & PARTNERS and its proceedings were handled in English The second opposition filed on April 21, 2020 by CHIESI FARMACEUTICI S.P.A. on Likelihood of confusion. the opponent was represented by GIAMBROCONO & C. S.P.A. and its proceedings were handled in English

The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on September 1, 2022.

The Opposition with reference B 003121738 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on June 15, 2021 by the EUIPO.


Goods And Services

  • The mark was filed in class 41 with following description of goods:
    1. Medical education services
    2. Conducting of educational seminars relating to medical matters
    3. Education services relating to medicine
    4. Provision of medical instruction courses
    5. Courses (Training -) relating to medicine
    6. Publishing of medical publications
    7. Publication of medical texts
    8. Publishing of journals, books and handbooks in the field of medicine.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services in the field of diabetes
    2. Providing information via the Internet in the field of diabetes
    3. Hiring of medical instruments
    4. Providing information relating to dietary and nutritional supplements
    5. Medical analysis for the diagnosis and treatment of persons
    6. Medical diagnostic services
    7. Pharmaceutical advice.